Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ALEC
ALECTOR, INC.
NASDAQ
$2.46
▼ DOWN 1.99% (-0.05)

KEY STATISTICS

Market Cap$273.12 M
52w High$3.40
52w Low$1.09
Dividend Yield—
Frequency—
P/E-2.24
Volume496.60K
Shares Out.111.03M

COMPANY

LEADERSHIP

Arnon Rosenthal
CHIEF EXECUTIVE
Arnon Rosenthal

COMPENSATION 2026

Salary$678,100
Stock Awards$422,876
Incentive Plan Pay$325,488
All Other Comp.$10,338
Total$1,995,018

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 7, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
103

PRICE TARGET

Target High$2.00
Target Low$2.00
Target Median$2.00
Target Consensus$2.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$2.93M
NOV
5
THU

PRICE

$2.46 ▼ DOWN 1.99% (−$0.05)
$2.44$2.48$2.52$2.569:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM2.46

About Alector, Inc.

https://www.alector.com ↗

Alector, Inc. is a clinical-stage biopharma developing antibody therapies for neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS, with multiple products in various clinical trial phases and collaborations with GSK and Adimab.

INDUSTRY

Biotechnology

A PRODUCT ALECTOR, INC. IS KNOWN FOR

Nivisnebart (AL101)
Nivisnebart (AL101)

Nivisnebart, an investigational antibody in Phase 2 for early Alzheimer's, aims to boost progranulin levels and is Alector's leading clinical candidate after discontinuing their previous GSK-collaborated drug.

COMPETITORS

COMPETITOR
ACAD COMPARE
ACIU COMPARE
AVXL COMPARE
BIIB COMPARE
DNLI COMPARE

Revenue by Products

IconPRODUCTQ3-2021
Phase Three License$173.4M

ETFS HOLDING THIS STOCK

ETFS HOLDING
69
LISTED HERE
13
RANKED BY POSITION SIZE
VTI
0.00% · 2.8M
IWM
0.01% · 2.5M
EMKT
0.46% · 2.3M
DX2D.DE
0.57% · 781.7K
AVES
0.02% · 739.8K
SCHA
0.00% · 437.6K
PRFZ
0.01% · 154.9K
R2SC.L
0.00% · 105.8K
RSSL
0.01% · 46.6K
DFSU
0.00% · 3.9K
URTY
0.00% · 3.9K
FSEG
0.07% · 1.9K
NIFE
0.41% · 1.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
69.66%
HOLDERS
212
TOP 12 OF 212 · RANKED BY POSITION SIZE
Fmr LLC
15.2M sh · $44.94M
Tcg Crossover Management, LLC
10.0M sh · $21.5M
Blackrock Inc.
9.1M sh · $41.32M
Blackrock, Inc.
7.7M sh · $16.64M
Rtw Investments, LP
7.0M sh · $20.69M
Vanguard Group Inc
6.9M sh · $10.78M
Acadian Asset Management LLC
4.0M sh · $8.68M
Foresite Capital Management Iv, LLC
3.9M sh · $6.06M
Merck & Co., Inc.
3.5M sh · $7.62M
683 Capital Management, LLC
3.4M sh · $5.23M
D. E. Shaw & Co., Inc.
3.3M sh · $7.17M
Balyasny Asset Management L.P.
3.3M sh · $5.09M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
OFFICER: PRINCIPAL ACCOUNTING OFFICER
Wong-Sarad Grace
Sale · 656 shares
2026-09-02
★
OFFICER: PRINCIPAL ACCOUNTING OFFICER
Wong-Sarad Grace
Sale · 5.2K shares
2026-09-03
★
OFFICER: PRINCIPAL ACCOUNTING OFFICER
Wong-Sarad Grace
Sale · 3.6K shares
2026-09-04
★
OFFICER: CFO & CHIEF BUSINESS OFFICER
Berkley Neil Lindsay
Sale · 29.3K shares
2026-09-03

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
OVERWEIGHT 1
HOLD 1
MARKET PERFORM 1
5 GRADES IN THE LAST 12 MONTHS
Cantor Fitzgerald OVERWEIGHT BTIG BUY HC Wainwright & Co. BUY TD Cowen HOLD William Blair MARKET PERFORM

SECTORS PEERS

PEERPRICE
VOR$25.05COMPARE
IRD$4.67COMPARE
FATE$2.48COMPARE
ABOS$3.18COMPARE
PEPG$3.11COMPARE
NKTX$2.92COMPARE
CRBP$11.08COMPARE
MOLN$4.35COMPARE